EUVIMEDEUVIMED entdecken
Kohortenstudie

Five-year recurrence rate of cutaneous squamous cell carcinoma after Mohs micrographic surgery versus standard excision: a prospective multicentre cohort study

Celeste J Eggermont iD, Emmy C Crüts iD, Charlotte B van Lee, Hanke C de Vijlder, Leonie Jacobs, Leon C C Wijne, Ruud G L Nellen, Annik van Rengen, Tamar Nijsten iD, Marlies Wakkee iD, Nicole W J Kelleners-Smeets, Renate R van den Bos

British Journal of Dermatology · 10.09.2026

DOI: 10.1093/bjd/ljag399 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift British Journal of Dermatology, online erschienen am 10.09.2026. Verfasst von Celeste J Eggermont und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. Die Arbeit nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mohs micrographic surgery (MMS) is a tissue-sparing alternative to standard excision (SE) for treatment of cutaneous squamous cell carcinoma (CSCC). Prospective studies comparing recurrence risk between MMS and SE remain limited, and no randomized controlled trials exist. In clinical practice, MMS tends to be selectively offered for higher-risk tumours in cosmetically sensitive areas.

Objectives

To compare 5-year recurrence rates between MMS and SE for primary CSCC, and to compare metastasis rates and the ratio of final defect size to initial tumour size.

Methods

This was a prospective multicentre cohort study of patients with primary CSCCs treated with MMS or SE in the Netherlands. To detect all recurrences, patients were linked to the Dutch Nationwide Pathology Databank. The Fine and Gray competing risk regression model was used to assess the subdistribution hazard ratio (sHR) for recurrence.

Results

A total of 761 patients with 903 completely excised primary CSCCs were included: 629 treated with SE and 274 with MMS. Tumours treated with MMS were more often classified as high stage according to the American Joint Committee on Cancer, eighth edition (AJCC 8) [≥ T2, 55.5% (n = 152/274) vs. 25.3% (n = 159/629); P < 0.001], and more frequently located in the H-zone [76.6% (n = 210/274) vs. 37.0% (n = 233/629), P < 0.001]. The 5-year cumulative incidence of recurrence was 1.7% (95% CI 0.9–3.0%) for SE and 3.3% (95% CI 1.6–5.9%) for MMS. After adjustment for AJCC 8 stage, the sHR for recurrence after MMS compared with SE was 1.51 (95% CI 0.66–3.44; P = 0.33). The 5-year cumulative incidence of metastasis was 0.8% (95% CI 0.3–1.8%) for SE and 1.1% (0.3–3.0%) for MMS. The ratio of final defect size to initial tumour size was smaller for MMS (1.2 vs. 3.0, P < 0.001).

Conclusions

No significant difference was found in 5-year recurrence rate between MMS and SE; however, definitive conclusions cannot be drawn about whether a true difference in efficacy exists. MMS resulted in smaller defects, supporting its use in cosmetically or functionally sensitive areas where tissue preservation is important.

Autor:innen und Institutionen

  • Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands. GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Department of Dermatology, Isala Hospital, Zwolle, the Netherlands.
  • Department of Dermatology, Amphia Hospital, Breda, the Netherlands.
  • Department of Dermatology, IJsseland Hospital, Capelle aan den IJssel, the Netherlands.
  • Department of Dermatology, Mohs Clinics, Dordrecht, the Netherlands.

ORCID-Profile: Celeste J Eggermont, Emmy C Crüts, Tamar Nijsten, Marlies Wakkee

Zitieren

APA

Eggermont, C. J., Crüts, E. C., van Lee, C. B., de Vijlder, H. C., Jacobs, L., Wijne, L. C. C., Nellen, R. G. L., van Rengen, A., Nijsten, T., Wakkee, M., Kelleners-Smeets, N. W. J., & van den Bos, R. R. (2026). Five-year recurrence rate of cutaneous squamous cell carcinoma after Mohs micrographic surgery versus standard excision: a prospective multicentre cohort study. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljag399

Vancouver

Eggermont CJ, Crüts EC, van Lee CB, de Vijlder HC, Jacobs L, Wijne LCC, et al. Five-year recurrence rate of cutaneous squamous cell carcinoma after Mohs micrographic surgery versus standard excision: a prospective multicentre cohort study. British Journal of Dermatology. 2026. doi:10.1093/bjd/ljag399

BibTeX
@article{Eggermont2026,
  author = {Eggermont, Celeste J and Crüts, Emmy C and van Lee, Charlotte B and de Vijlder, Hanke C and Jacobs, Leonie and Wijne, Leon C C and Nellen, Ruud G L and van Rengen, Annik and Nijsten, Tamar and Wakkee, Marlies and Kelleners-Smeets, Nicole W J and van den Bos, Renate R},
  title = {Five-year recurrence rate of cutaneous squamous cell carcinoma after Mohs micrographic surgery versus standard excision: a prospective multicentre cohort study},
  journal = {British Journal of Dermatology},
  year = {2026},
  doi = {10.1093/bjd/ljag399}
}
Kostenlos starten →